|
|
42
|
|
|
4181PB
|
|
|
SIMULECT 20MG INJ (NVS) BASILIXIMAB
|
|
|
BASILIXIMAB
|
|
|
SIMULECT
|
|
|
20MG VIAL
|
|
|
C
|
|
|
4,892.98
|
|
|
4,892.98
|
|
|
20MG
|
|
|
VIAL
|
|
|
0
|
|
|
VIAL
|
|
|
NVS
|
|
|
NOVARTIS CARIBE SA
|
|
|
COL
|
|
|
AVENTA BARBADOS
|
|
|
|
|
|
|
|
|
2026-04-01
|
|
|
2028-03-31
|
|
|
No
|
|
|
No
|
|
|
|
|
|
0
|
|
|
N
|
|
|
1000
|
|
|
ANTINEOPLASTICS
|
|
|
|
|
|
IV
|
|
|
0
|
|
|
ANTINEOPLASTICS
|
|
|
|